Hualan Biological Vaccine Dividends and Buybacks
Dividend criteria checks 4/6
Hualan Biological Vaccine is a dividend paying company with a current yield of 2.97% that is well covered by earnings.
Key information
3.0%
Dividend yield
-0.1%
Buyback Yield
| Total Shareholder Yield | 2.8% |
| Future Dividend Yield | 5.4% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.600 |
| Payout ratio | 72% |
Recent dividend and buyback updates
Recent updates
Hualan Biological Vaccine (SZSE:301207) Seems To Use Debt Rather Sparingly
Oct 08
Potential Upside For Hualan Biological Vaccine Inc. (SZSE:301207) Not Without Risk
Jul 25Hualan Biological Vaccine's (SZSE:301207) Upcoming Dividend Will Be Larger Than Last Year's
Jun 11Revenue Downgrade: Here's What Analysts Forecast For Hualan Biological Vaccine Inc. (SZSE:301207)
Apr 03Hualan Biological Vaccine Inc. Just Missed Revenue By 9.2%: Here's What Analysts Think Will Happen Next
Apr 02Hualan Biological Vaccine Inc.'s (SZSE:301207) Subdued P/E Might Signal An Opportunity
Apr 01An Intrinsic Calculation For Hualan Biological Vaccine Inc. (SZSE:301207) Suggests It's 31% Undervalued
Mar 04Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, 301207 has been paying a dividend for less than 10 years.
Growing Dividend: 301207's dividend payments have increased, but the company has only paid a dividend for 3 years.
Dividend Yield vs Market
| Hualan Biological Vaccine Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (301207) | 3.0% |
| Market Bottom 25% (CN) | 0.5% |
| Market Top 25% (CN) | 2.1% |
| Industry Average (Biotechs) | 1.2% |
| Analyst forecast (301207) (up to 3 years) | 5.4% |
Notable Dividend: 301207's dividend (2.97%) is higher than the bottom 25% of dividend payers in the CN market (0.56%).
High Dividend: 301207's dividend (2.97%) is in the top 25% of dividend payers in the CN market (2.17%)
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (72.3%), 301207's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (51.4%), 301207's dividend payments are covered by cash flows.